Want to see LCTC full AI Analyst Report?
Lifeloc Technologies (LCTC) AI Stock Analysis
Lifeloc Technologies
(Other OTC:LCTC)
The score is driven mainly by mixed fundamentals: strong TTM revenue rebound and a meaningfully de-risked balance sheet are positives, but ongoing losses keep financial quality moderate. Technicals add support with an established uptrend and constructive momentum, while valuation is constrained by the negative P/E. A modest positive corporate event improves visibility but is not sufficient to outweigh profitability risk.
Lifeloc Technologies (LCTC) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $9.63M
- Dividend Yield
- ―
- Average Volume (3M)
- 2,287
- Price to Earnings (P/E)
- -4.6
- Beta (1Y)
- 0.27
- Revenue Growth
- 9.13%
- EPS Growth
- -75.10%
- Country
- US
- Employees
- 37
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Hardware, Equipment & Parts
Lifeloc Technologies Business Overview & Revenue Model
Company Description
Lifeloc Technologies, Inc. develops, manufactures, and markets portable hand-held and fixed station breathalyzers and related accessories for law enforcement, workplace, corrections, original equipment manufacturing, and consumer markets worldwide. I...
How the Company Makes Money
Lifeloc Technologies makes money primarily by selling alcohol detection hardware and related products to commercial and governmental customers. Key revenue streams include: (1) Product sales of breath alcohol testing devices (e.g., handheld/portable...
Lifeloc Technologies Financial Statement Overview
Summary
Revenue rebounded sharply (+249% TTM) and gross margin improved (~42%), while the balance sheet is now conservatively levered (very low debt-to-equity ~0.03). Offsetting this, profitability remains weak (TTM net margin about -22% with negative EBIT/EBITDA) and cash flow consistency is still a concern despite recent positive operating and free cash flow.
Income Statement
38NegativeBalance Sheet
66PositiveCash Flow
55Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.27M | 9.03M | 8.54M | 9.33M | 8.48M | 7.05M |
| Gross Profit | 3.89M | 3.64M | 3.45M | 4.04M | 3.07M | 3.06M |
| EBITDA | -463.08K | -786.57K | -1.07M | 143.75K | 102.76K | 925.75K |
| Net Income | -2.07M | -2.47M | -1.05M | 205.61K | -455.76K | 675.97K |
Balance Sheet | ||||||
| Total Assets | 7.08M | 6.69M | 8.72M | 8.69M | 8.52M | 8.95M |
| Cash, Cash Equivalents and Short-Term Investments | 908.21K | 746.00K | 1.24M | 1.77M | 2.35M | 2.57M |
| Total Debt | 2.28M | 1.83M | 1.80M | 1.22M | 1.27M | 1.32M |
| Total Liabilities | 3.26M | 2.58M | 2.50M | 2.33M | 2.36M | 2.36M |
| Stockholders Equity | 3.82M | 4.10M | 6.23M | 6.36M | 6.16M | 6.59M |
Cash Flow | ||||||
| Free Cash Flow | 562.84K | -460.77K | -2.02M | -533.96K | -168.25K | -85.53K |
| Operating Cash Flow | 472.75K | 2,025 | -1.33M | -525.74K | 54.33K | 182.94K |
| Investing Cash Flow | -112.13K | -354.38K | -689.45K | -8,215 | -222.58K | -268.48K |
| Financing Cash Flow | 416.69K | 355.95K | 1.49M | -52.18K | -50.66K | 462.13K |
Lifeloc Technologies Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LCTC, the sentiment is Negative. The current price of 3.50 is below the 20-day moving average (MA) of 3.58, below the 50-day MA of 3.88, and above the 200-day MA of 2.88, indicating a neutral trend. The MACD of -0.11 indicates Negative momentum. The RSI at 41.16 is Neutral, neither overbought nor oversold. The STOCH value of 40.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LCTC.
Lifeloc Technologies Risk Analysis
Lifeloc Technologies disclosed 36 risk factors in its most recent earnings report. Lifeloc Technologies reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
1 New RiskLifeloc Technologies Peers Comparison
Overall Rating
- LCTC59Neutral
CPSH48Neutral
KULR42Neutral
LINK41Neutral
REFR38Underperform
SOBR38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| LCTC | 59Neutral | $9.63M | -4.64 | -47.35% | ― | 9.13% | -75.10% |
| CPSH | 48Neutral | $69.60M | 780.43 | 0.15% | ― | 25.56% | ― |
| KULR | 42Neutral | $75.90M | -0.74 | -92.81% | ― | 28.49% | -296.38% |
| LINK | 41Neutral | $59.71M | -48.59 | -10.92% | ― | 7.85% | 45.80% |
| REFR | 38Underperform | $12.21M | -5.30 | -168.53% | ― | -46.47% | -26.00% |
| SOBR | 38Underperform | $355.56K | -0.04 | -310.87% | ― | 17.67% | 92.17% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| LCTC | Lifeloc Technologies | 3.50 | 0.40 | 12.90% | |
| REFR | Research Frontiers | 0.35 | -1.53 | -81.38% | |
| CPSH | CPS Technologies Corp. | 3.59 | 0.10 | 2.87% | |
| LINK | Interlink Electronics, Inc. | 3.79 | -2.37 | -38.47% | |
| SOBR | Sobr Safe, Inc. | 0.07 | -3.04 | -97.88% | |
| KULR | KULR Technology Group | 1.64 | -1.88 | -53.41% |
Lifeloc Technologies Corporate Events
Lifeloc Technologies Highlights Growth at Lytham Investor Conference
PositiveOn September 28, 2026, Lifeloc Technologies announced it will participate in the virtual Lytham Partners Fall 2026 Investor Conference, scheduled for September 29-30, 2026. The company will deliver a webcast presentation on September 29 at 2:45 p.m....
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 29, 2026